---
title: Anticoagulants (Incomplete)
layout: diseases
author: Corbin Cox
last-updated: 2018-1-22
created: 2018-1-22
---

# Coagulation Cascade

![Coagulation Cascade](../images/coagulation_cascade.png)

Clotting Factors are produced exclusively in the liver, with the exception of vWF (endothelium, subendothelium, and megakaryocytes) and Factor VIII (liver and endothelium). The cascade begins when Tissue Factor (TF) binds to Factor VII after vascular wall injury exposes extra-vascular tissue. This process begins the extrinisic pathway. The intrinsic pathway is initiated by thrombin (Factor IIa) cleaving Factor XII in response to exposed collagen from damaged endothelial cells. The coagulation cascade is naturally inhibited by Antithrombin III (AT, neutralizes Thrombin, Xa, and IXa), Protein C (neutralizes Va and VIIIa), and Xa (activates Tissue Factor Pathway Inhibitor).

# Lab Tests

| Test           | Evaluating        | Low  | High | Units            |
| -------------- | ----------------- | ---- | ---- | ---------------- |
| Platelet Count | Bone Marrow       | 150  | 450  | k/mm<sup>3</sup> |
| PT             | Extrinsic Pathway | 12   | 14   | sec              |
| INR            | Extrinsic Pathway | -    | 1.1  | n/a              |
| aPTT           | Intrinsic Pathway | 26   | 33   | sec              |

$$
\text{INR} = \left(  \frac{\text{PT}_{test}}{\text{PT}_{normal}} \right)^\text{ISI}
$$

| Anticoagulant       | PT/INR | aPTT | Anti-Xa Activity | Activated Clotting Time | Thrombin Time | Ecarin Clotting Time |
| ------------------- | ------ | ---- | ---------------- | ----------------------- | ------------- | -------------------- |
| Warfarin            | +*     | +/-  | -                | +                       | -             | No sig. Data         |
| UFH                 | -      | +*   | +                | +*                      | +             | -                    |
| LMWH                | -      | +/-  | +*               | +/-                     | +             | No sig. Data         |
| Fondaparinux        | -      | +/-  | +*               | -                       | -             | No sig. Data         |
| Rivaroxaban         | +      | +/-  | +                | +/-                     | -             | -                    |
| Edoxaban / Apixaban | +/-    | +/-  | +                | No sig. Data            | -             | -                    |
| Dabigatran          | +/-    | +    | +/-              | -                       | +*            | +*                   |

(* Prefered Test, + Higher Values, - No Effect, +/- Inconsistent Effect)

# Anticoagulant Classes

* Vitamin K Antagonists
  * Warfarin
* Factor Xa Inhibitors
  * Direct: Rivaroxiban, Apixaban, and Edoxaban
  * Indirect: Unfractionated Heparin, LMWH (Enoxaparin / Daltaparin), Fondaparinux
* Direct Thrombin Inhibitors
  * Dabigatran

# Warfarin

**MOA:** Inhibition of Post-Translational Modification of Factors II (Prothrombin), VII, IX, and X along with  Proteins C and S



# References

* Coagulation Cascade Image Available at [http://upload.medbullets.com/topic/111004/images/750px-coagulation_full.svg.jpg](http://upload.medbullets.com/topic/111004/images/750px-coagulation_full.svg.jpg)